Regadenoson Injection, Solution
Product Images NDC 36000-364

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 36000-364). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-3 (Carton 3)

Packaging label for Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) intravenous solution by Baxter Healthcare Corporation. The label indicates it is a single-dose pre-filled syringe used as a pharmacologic stress agent for diagnostic purposes, with instructions for aseptic technique and storage details. Manufactured by Baxter Pharmaceutical Solutions, LLC.*

FDA Label Image

Container-2 (Container 2)

Label for Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) in a 5 mL single-dose pre-filled syringe. Intended for intravenous use only, manufactured by Baxter Healthcare Corporation in Deerfield, IL, USA. The label specifies use for pharmacologic stress only and includes barcodes and space for lot and expiration information.*

FDA Label Image

Description-1 (Description 1)

Chemical structure of regadenoson, showing its molecular framework with labeled functional groups including amide, purine-like ring, and sugar moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.